HomeMBRX • NASDAQ
Moleculin Biotech Inc
add
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.14M | 19.98% |
Net income | -10.59M | -88.84% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -7.10M | -20.06% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.41M | -61.74% |
Total assets | 23.39M | -40.81% |
Total liabilities | 15.92M | 262.94% |
Total equity | 7.48M | — |
Shares outstanding | 3.00M | — |
Price to book | 0.51 | — |
Return on assets | -72.85% | — |
Return on capital | -136.05% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -10.59M | -88.84% |
Cash from operations | -6.11M | 19.04% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 4.66M | 116,575.00% |
Net change in cash | -1.44M | 81.04% |
Free cash flow | -3.55M | 38.76% |
Previous close
$1.26
Day range
$1.15 - $1.29
Year range
$0.40 - $8.85
Market cap
3.57M USD
Avg Volume
11.27M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Headquarters
Website
Employees
18
